Androgens and the control of skeletal muscle protein synthesis

References

• Biolo G, Chinkes D, Zhang X, Wolfe R R. A new model to determine in vivo the relationship between amino acid transmembrane transport and protein kinetics in muscle. J Parenter Enteral Nutr 1992; 16: 305–15
   PubMedGoogle Scholar
• Wolfe R R. Radioactive and stable isotope tracers in biomedicine: principles and practices in kinetic analysis. Wiley-Liss, New York, NY 1992
   Google Scholar
• Trapman J, Klanssen P, Kuiper G GJM, van der Korput J AGM, Faber P W, van Rooij H CJ, et al. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988; 153: 241–8
   PubMed Web of Science ®Google Scholar
• Tilley W D, Marcelli M, Wilson J D, McPhaul M J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Nutl Acad Sci USA 1989; 86: 327–31
   PubMed Web of Science ®Google Scholar
• Lubahn D B, Joseph D R, Sullivan P M, Willard H F, French F S, Wilson E M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240: 327–30
   PubMed Web of Science ®Google Scholar
• Chang C, Kokontis J, Liao S. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988; 240: 324–6
   PubMed Web of Science ®Google Scholar
• Siiteri P K, MacDonald P C. Role of extraglandular estrogen in human endocrinology. Handbook of physiology II, section 7, endocrinology, R O Greep, E B Astwood. American Physiological Society, Washington, DC 1973; 615–29
   Google Scholar
• Wilson J D, Aiman J, MacDonald P C. The pathogenesis of gynecomastia. Adv Intern Med 1980; 25: 1–32
   PubMedGoogle Scholar
• Moore R J, Gazak J M, Wilson J D. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17B-estradiol. J Clin Invest 1979; 63: 351–7
   PubMed Web of Science ®Google Scholar
• Griffin J E, Wilson J D. Disorders of the testes and the male reproductive tract. Williams textbook of endocrinology, J D Wilson, D W Foster, H M Kronenberg, P R Larsen. WB Saunders, Philadelphia, PA 1998; 819–75
   Google Scholar
• Griggs R C, Kingston W, Jozefowicz R F, Herr B E, Forbes G, Hdiday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989; 66: 498–503
   PubMed Web of Science ®Google Scholar
• Ferrando A A, Tipton K D, Doyle D, Phillips S M, Cortiella J, Wolfe R R. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol 1998; 275: E864–71
   PubMedGoogle Scholar
• Sheffield-Moore M, Urban R J, Wolf S E, Jiang J, Catlin D H, Herndon D N, et al. Short term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 1999; 84: 2705–11
   PubMed Web of Science ®Google Scholar
• Brodsky I G, Balagopal P, Nair K S. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men — a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3469–75
   PubMed Web of Science ®Google Scholar
• Katznelson L, Kinkelstein J S, Schoenfeld D A, Rosenthal D I, Anderson E J, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81: 4358–65
   PubMed Web of Science ®Google Scholar
• Bhasin S, Storer T W, Berman N, Yarasheski K E, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 407–13
   PubMed Web of Science ®Google Scholar
• Tenover J S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092–8
   PubMed Web of Science ®Google Scholar
• Urban R J, Bodenburg C, Gilkison C, Foxworth J, Coggan A R, Wolfe R R, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995; 269: E820–6
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, et al. Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996; 81: 4051–8
   PubMed Web of Science ®Google Scholar
• Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in parrafin-embedded human tissues. J Histochem Cytochem 1993; 41: 671–8
   PubMed Web of Science ®Google Scholar
• Chang C, Kokontis J, Liao S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988; 85: 7211–5
   PubMed Web of Science ®Google Scholar
• Wilson J D, Gloyna E. The intranuclear metabolism of testosterone in the accessory organs of male reproduction. Rec Prog Horm Res 1970; 26: 309–36
   PubMedGoogle Scholar
• Brinkman A O, Blok L J, deRuiter P E, Doesberg P, Steketee K, Berrevoets C A, et al. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999; 69: 307–13
   PubMedGoogle Scholar
• Inoue K, Yamasaki S, Fushiki T, Okada Y, Sugimoto E. Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle. Eur J Appl Physiol 1994; 69: 88–91
   PubMedGoogle Scholar
• Verhoeven G, Swinnen J V. Indirect mechanisms and cascades of androgen action. Mol Cell Endocrinol 1999; 151: 205–12
   PubMedGoogle Scholar
• Arnold A M, Peralta J M, Thonney M L. Ontogeny of growth hormone, insulin-like growth factor-I, estrodiol and cortisol in the growing lamb: effect of testosterone. J Endocrinol 1996; 150: 391–9
   PubMedGoogle Scholar
• Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998; 83: 1886–92
   PubMed Web of Science ®Google Scholar
• Hayes V, Jiang J, Urban R J, Mauras N (1999) IGF-I and androgenic steroids: synergistic effects in man. Proceedings from the 81st Annual Meeting of the Endocrine Society. June, 12–151999. The Endocrine Society Press, San Diego, CA, 571
   Google Scholar
• Doumit M E, Cook D R, Merkel R A. Testosterone upregulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 1996; 137: 1385–94
   PubMedGoogle Scholar
• Fryburg D A. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Pbysiol 1994; 267: E331–6
   Google Scholar
• Wolfe R, Fernando A, Sheffield-Moore M, Urban R. Testosterone and muscle protein metabolism. Muyo Clin Proc 2000; 15(Suppl.)S55–60
   Google Scholar
• Hickson R C, Czerwinski S M, Falduto M T, Young A P. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med Sci Sports Exerc 1990; 22: 331–40
   PubMedGoogle Scholar
• Misrahi M, Atger M, d'Auriol L, Loosfelt H, Meriel C, Frindlansky F, et al. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biocbem Biopbys Res Commun 1987; 143: 740–8
   PubMed Web of Science ®Google Scholar
• Arriza J L, Weinberger C, Cerelli G, Glaser T M, Handelin B L, Housman D E, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268–75
   PubMed Web of Science ®Google Scholar
• Hollenberg S M, Weinberger C, Ong E S, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635–41
   PubMed Web of Science ®Google Scholar
• Green S, Walter P, Kumar V, Krust A, Bornert J M, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to. v-erb-A. Nature 1986; 320: 134–9
   PubMed Web of Science ®Google Scholar
• Danhaive P A, Rousseau G G. Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. J Steroid Biocbem Mol Biol 1986; 24: 481–7
   Google Scholar
• Danhaive P A, Rousseau G G. Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat. J Steroid Biocbw Mol Biol 1988; 29: 575–81
   Google Scholar
• Wu F CW. Endocrine aspects of anabolic steroids. Clin Chem 1997; 43: 1289–92
   PubMed Web of Science ®Google Scholar
• Woolf P D. Hormonal responses to trauma. Crit Cure Med 1992; 20: 216–26
   PubMed Web of Science ®Google Scholar
• Vaughn G M, Becker R A, Allen J P, Goodwin C W, Jr, Pruitt B A, Jr, Mason A D, Jr. Cortisol and corticotropin in burned patients. J Trauma 1982; 22: 263–73
   PubMedGoogle Scholar
• Fernando A A, Sheffield-Moore M, Wolf S E, Herndon D N, Wolfe R R. Testosterone normalization in severe burns ameliorates muscle catabolism. J FASEB 2000; 14(4)A 797
   PubMedGoogle Scholar
• McPherron A C, Lawler A M, Lee S -J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acud Sci USA 1997; 94: 12457–61
   PubMed Web of Science ®Google Scholar
• Grobet L, Martin L JR, Poncelet D, Pirottin D, Brouwers B, Riquet J, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nut Genet 1997; 17: 71–4
   PubMed Web of Science ®Google Scholar
• McPherron A C, Lawler A M, Lee S -J. Regulation of skeletal muscle mass in mice by a new TGF-B superfamily member. Nature 1997; 387: 83–90
   PubMed Web of Science ®Google Scholar
• Gonzales-Cadavid N F, Taylor W E, Yarasheski K E, Sinha-Hikim I, Ma K, Ezzat S, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acud Sci USA 1998; 95: 14938–43
   PubMedGoogle Scholar
• Sussman M A, Lim H W, Gude N, Taigen T, Olson E N, Robbins J, et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998; 281: 1690–3
   PubMed Web of Science ®Google Scholar
• Molkentin J D, Lu J -R, Antos C L, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215–28
   PubMed Web of Science ®Google Scholar
• Dunn S E, Bums J L, Michel R N. Calcineurin is required for skeletal muscle hypertrophy. J Biol Cbem 1999; 274: 21908–12
   Google Scholar
• Barton-Davis E, Shoturma D L, Musaro A, Rosenthal N, Sweeney H L. Viral mediated expression of IGF-1 blocks the aging-related loss of skeletal muscle function. Proc Natl Acud Sci USA 1998; 95: 15603
   PubMed Web of Science ®Google Scholar
• Musaro A, McCullagh K JA, Naya F J, Olson E N, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATcl. Nature 1999; 400: 581–5
   PubMed Web of Science ®Google Scholar
• Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metub 1999; 84: 3459–62
   PubMed Web of Science ®Google Scholar
• Baracat E, Haidar M, Lopez F J, Pickar J, Dey M, Negro-Viar A. Estrogen activity and novel tissue selectivity of Δ8,9 dehydroestrone sulfate in postmenopausal women. 1. Clin Endocrinol Metub 1999; 84: 2020–7
   PubMedGoogle Scholar
• Cosman F, Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 1999; 20: 418–34
   PubMed Web of Science ®Google Scholar